Management of chronic thromboembolic pulmonary hypertension (CTEPH) includes multimodal therapy that depends on expert ...

E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism ...

According to Nova One Advisor, the global pulmonary embolism market size is calculated at USD 2.15 billion in 2024, grows to USD 2.33 billion in 2025, and is projected to hit around USD 4.78 billion ...

Penumbra announced today that it completed enrollment in the STORM-PE trial of its Lightning Flash system.

Michael Matthews ruled out of Tour de France and sidelined as team discover 'signs of a pulmonary embolism' at altitude camp By James Moultrie published 13 June 2025 ...

A three-person adjudication panel diagnosed pulmonary embolism via imaging including pulmonary vascular imaging and compression venous ultrasound for deep vein thrombosis within 45 days.

Pulmonary embolism in children has been acknowledged to be an issue in clinical care but was thought to be rare. Now new research published at the ATS 2025 International Conference shows that it ...

The AVENTUS Trial successfully met its primary endpoints, demonstrating both safety and efficacy in the treatment of acute intermediate-risk pulmonary embolism (PE) patients.

Right ventricular strain and right ventricular outflow tract velocity time integral are associated with mortality in critically ill patients with pulmonary embolism.

Photo Credit: Frepick The following is a summary of “Diagnostic accuracy of multi-organ point-of-care ultrasound for pulmonary embolism in critically ill patients: a systematic review and ...

A subsegmental pulmonary embolism is a blood clot located on a distal, or distant and less central, branch of the pulmonary arteries. Treatment can depend on symptoms and risk factors.

A scientific statement regarding disparities in current pulmonary embolism management and outcomes has been published by the AHA.